Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Aurora(R) Breast MRI Society Debuts The Journal Of Breast MRI
http://www.medicalnewstoday.com/articles/114389.php
The Aurora® Breast MRI Society, a rapidly growing group of dedicated breast health specialists committed to advancing the use of cutting-edge dedicated breast MRI technology, debuted its inaugural issue of <i>The Journal of Breast MRI.
Risk Prediction For Breast Cancer Not Substantially Improved By Single-Nucleotide Polymorphisms
http://www.medicalnewstoday.com/articles/114386.php
Recently identified genetic markers, called single nucleotide polymorphisms (SNPs), that are associated with a small but statistically significant increase in the risk of breast cancer do not appear to substantially improve the accuracy of existing models that use clinical factors to predict an individual's risk, according to a study in the July 8 online issue of the <i>Journal of the National Cancer Institute.
Breast Cancer HER2 Test For Herceptin Candidates Approved By FDA
http://www.medicalnewstoday.com/articles/114372.php
The US Food and Drug Administration (FDA) announced on Tuesday that it had approved a new test that measures the strength of HER2 gene amplification in breast cancer patients so that decisions can be made about whether they should be given the cancer drug Herceptin (trastuzumab).
Physicians Debate Value Of Routine Breast Cancer Screenings For Elderly Patients
http://www.medicalnewstoday.com/articles/114359.php
Although annual breast cancer screenings are recommended for most women ages 40 and older, physicians debate the value of regular mammograms for elderly women, who are more likely to die from unrelated causes, the <a href="http://www.
Antibody To Breast Cancer-Secreted Protein Blocks Metastasis
http://www.medicalnewstoday.com/articles/114332.php
Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have made a key discovery about the mechanism of breast cancer metastasis, the process by which cancer spreads.
Breast Asymmetry After Cancer Treatment Affects Quality Of Life
http://www.medicalnewstoday.com/articles/114318.php
Most women with breast cancer assume that surgery to preserve their breast will be less disfiguring than a mastectomy that removes the entire breast.But nearly one-third of women reported pronounced asymmetry between their breasts, and that perceived disfigurement greatly affects a woman's quality of life after treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
FDA Approves New Genetic Test For Patients With Breast Cancer
http://www.medicalnewstoday.com/articles/114287.php
The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
----------------------------------------------
** CANCER / ONCOLOGY News **
Better Counseling By Physicians Recommended Regarding Link Between Smoking And Bladder Cancer
http://www.medicalnewstoday.com/articles/114403.php
Even though cigarette smoking accounts for up to half of all bladder cancer cases, few people are aware of the connection - including more than three-quarters of patients who have bladder cancer, according to a new study from the University of Michigan Comprehensive Cancer Center.
Cancer And Tropical Disease Drug Discovery Aided By Insect Warning Colors
http://www.medicalnewstoday.com/articles/114395.php
Brightly colored beetles or butterfly larvae nibbling on a plant may signal the presence of chemical compounds active against cancer cell lines and tropical parasitic diseases, according to researchers at Smithsonian's Tropical Research Institute in Panama.
First Twenty-Five Percent Of Subjects In Phase 2 Melanoma Clinical Trial Treated
http://www.medicalnewstoday.com/articles/114390.php
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that the first twenty-five percent (20 of 80) of melanoma subjects have been treated in Provectus Pharmaceuticals' Phase 2 clinical trial of PV-10.
pSivida Corp: BrachySil™ Phase IIb Pancreatic Cancer Trials Commence
http://www.medicalnewstoday.com/articles/114387.php
pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PSI), a global drug delivery company announced that a Phase IIb clinical trial has commenced with BrachySil™ (P32 BioSilicon™) as a potential new brachytherapy treatment for inoperable pancreatic cancer.
Awareness Of Epidemiology's Limitations Could Reduce Impact Of False-Positive Cancer Results
http://www.medicalnewstoday.com/articles/114382.php
False-positive results are an inherent risk in cancer research, particularly in observational epidemiology studies. The frequency and impact of misleading results can be mitigated if researchers use more exacting standards when interpreting and reporting results, according to a commentary in the July 8 online issue of the <i>Journal of the National Cancer Institute</i>.
News From The July 8 Journal Of The National Cancer Institute
http://www.medicalnewstoday.com/articles/114380.php
<b>Reductions in Iron Blood Levels Associated with Decreased Cancer Risk in Men with Peripheral Arterial Disease</b>Men with peripheral arterial disease who participated in a randomized controlled trial in which their iron stores were reduced by blood drawing had a reduced incidence of cancer relative to men in the trial who did not undergo blood letting.
Stanford Researchers Find Molecule That Kills Kidney Cancer Cells
http://www.medicalnewstoday.com/articles/114379.php
Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ. But that could change, thanks to a new molecule found by Stanford University School of Medicine researchers that kills kidney cancer cells.
Changes In Doctors' Reimbursement Has Not Affected Access To Cancer Care
http://www.medicalnewstoday.com/articles/114376.php
The Medicare Modernization Act of 2003, which reduced the amount of money doctors are reimbursed for the delivery of chemotherapy treatments, has not harmed patients' access to care in the way critics feared it might, according to a new study, led by investigators from the Duke Clinical Research Institute (DCRI).
Wall Street Journal Examines How Costly Cancer Drugs Affect Physicians' Treatment Decisions
http://www.medicalnewstoday.com/articles/114354.php
The <cite>Wall Street Journal</cite> on Tuesday examined how "hyperexpensive cancer drugs" are causing oncologists to go into debt and potentially interfering with treatment decisions. According to the <cite>Journal</cite>, a "new generation of cancer drugs," including <a href="http://www.
Argyrin: Natural Substance Raises Hope For New Cancer Therapies
http://www.medicalnewstoday.com/articles/114325.php
The effective treatment of many forms of cancer continues to pose a major problem for medicine. Many tumours fail to respond to standard forms of chemotherapy or become resistant to the medication.
Epeius Biotechnologies' Tumor Targeted Rexin G Receives FDA Orphan Drug Designation For The Treatment Of Osteosarcoma
http://www.medicalnewstoday.com/articles/114313.php
Epeius Biotechnologies Corporation announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of osteosarcoma. Based on several criteria, including the rarity, seriousness, and current lack of effective therapies for metastatic osteosarcoma, as well as the scientific and medicinal merit of Rexin-G, the granting of Orphan Drug Status by the FDA validates the unique clinical development strategy of Epeius Biotechnologies: that is, to demonstrate the profound single-agent efficacy of Rexin-G where traditional treatments have historically failed.
Online Cancer Chat With A Safety Net
http://www.medicalnewstoday.com/articles/114284.php
Cancer Research UK launches an online chat forum for cancer patients to swap stories and share experiences on how to cope with such a devastating disease. But <a href="http://www.cancerchat.org.
No Major Changes Seen In Access To Chemotherapy After Medicare Modernization Act Of 2003
http://www.medicalnewstoday.com/articles/114128.php
When the Medicare Modernization Act of 2003 was passed by Congress andsigned by President George W. Bush, there were still several concernsthat it would have a substantially negative effect on chemotherapypatients because of the stipulated reductions in reimbursements tophysicians for drugs given during outpatientchemotherapy care.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
HPV Vaccine Gardasil Under Investigation For Adverse Events, New York Post Reports
http://www.medicalnewstoday.com/articles/114346.php
<BR />Lawyers for two girls who received <A href="http://www.merck.com/" target=_new>Merck</A>'s human papillomavirus vaccine Gardasil last month filed the first two claims under the federal <A href="http://www.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
Greater Gains In Mortality Reduction From Common Cancers Associated With Higher Education
http://www.medicalnewstoday.com/articles/114383.php
Deaths due to the four most common cancers - lung, colorectal, prostate, and breast - have dropped substantially in the United States from 1993 to 2001 in working-aged individuals. However, not all Americans are equally likely to benefit from those gains.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Greater Gains In Mortality Reduction From Common Cancers Associated With Higher Education
http://www.medicalnewstoday.com/articles/114383.php
Deaths due to the four most common cancers - lung, colorectal, prostate, and breast - have dropped substantially in the United States from 1993 to 2001 in working-aged individuals. However, not all Americans are equally likely to benefit from those gains.
Survival Benefit Lacks For Some Prostate Patients Given Hormones
http://www.medicalnewstoday.com/articles/114319.php
New research to be published in tomorrow's issue of <I>JAMA</I> (Vol. 300, No. 2) by a team of investigators at The Cancer Institute of New Jersey (CINJ), shows a lack of survival benefit for older men with localized prostate cancer when administered a common therapy.
No Improvement In Survival With Hormone Therapy For Prostate Cancer
http://www.medicalnewstoday.com/articles/114023.php
An article published in the July 9 issue of <i>JAMA</i>finds that elderly men with localized prostate cancer had noimprovement in survival when treated with a therapy that deprives theprostate gland of androgen (a male hormone) compared to conservativemanagement of the disease.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment